documentation:international_drugs
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| documentation:international_drugs [2019/07/24 14:09] – ekorchmar | documentation:international_drugs [2024/09/02 12:35] (current) – Depreciation of page and posting of corresponding link in Github wiki jcruz | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| ===== RxNorm Extension - an OHDSI resource to represent international drugs ===== | ===== RxNorm Extension - an OHDSI resource to represent international drugs ===== | ||
| - | The purpose of this document is to define | + | Thank you for visiting |
| - | + | ||
| - | Drug vocabularies contain drug products and their components. Only about a third of these products are identical in the drug markets of individual countries or jurisdictions of a drug marketing approval agency. Even if the active ingredients are the same, they can differ in their Drug Strengths, Drug Forms, Brand Names, package sizes and manufacturers or distributors. | + | |
| - | + | ||
| - | Therefore, these vocabularies need to be incorporated into the existing Drug Domain in such a way that all existing drugs and their components are correctly mapped, and the missing ones added as new concepts. | + | |
| - | + | ||
| - | The processing script that follows these instructions can be found [[https:// | + | |
| - | + | ||
| - | ==== General structure ==== | + | |
| - | The Drug Domain should be organized in a hierarchical structure described [[documentation: | + | |
| - | + | ||
| - | This structure contains at a minimum (from bottom to top): | + | |
| - | + | ||
| - | ^ Concept Class ^ Composed of ^ | + | |
| - | | Branded Drug | Ingredients, | + | |
| - | | Clinical Drug | Ingredient, their strength, form | | + | |
| - | | Branded Drug Form | Ingredient, form, brand name | | + | |
| - | | Clinical Drug Form | Ingredient, form | | + | |
| - | | Branded Drug Component | + | |
| - | | Clinical Drug Component | + | |
| - | | Dose Form | Form | | + | |
| - | | Brand Name | Brand name | | + | |
| - | | Ingredient | + | |
| - | | Drug Class | Drug class | | + | |
| - | + | ||
| - | It may optionally contain | + | |
| - | ^ Concept Class ^ Composed of ^ | + | |
| - | | Marketed Product | + | |
| - | | Quantified Branded Drug Box | Ingredients, | + | |
| - | | Quantified Clinical Drug Box | Ingredients, | + | |
| - | | Branded Drug Box | Ingredients, | + | |
| - | | Clinical Drug Box | Ingredients, | + | |
| - | | Quantified Branded Drug | Ingredients, | + | |
| - | | Quantified Clinical Drug | Ingredients, | + | |
| - | | Branded Pack | Branded Drugs, their number (box size is optional) | + | |
| - | | Clinical Pack | Clinical Drugs, their number (box size is optional) | + | |
| - | | Supplier | + | |
| - | + | ||
| - | Currently not supported in the Standardized Vocabularies: | + | |
| - | ^ Concept Class ^ Composed of ^ Note ^ | + | |
| - | | Precise Ingredient | + | |
| - | | Multiple Ingredient | + | |
| - | | Dose Form Group | Dose Form | Explicit Dose Forms used instead; Dose Form Groups exist as Classification concepts and bear relation to standard concepts only inside native RxNorm vocabulary | + | |
| - | + | ||
| - | The Concepts are connected through hierarchical and lateral relationships. | + | |
| - | + | ||
| - | ==== Combined target structure ==== | + | |
| - | To incorporate a new set of drug information, | + | |
| - | + | ||
| - | In order to achieve this, any two equivalent Concepts have to be matched through its components: Ingredients to Ingredients, | + | |
| - | + | ||
| - | For specifics, see [[: | + | |
| - | + | ||
| - | ==== Rules for adding Concepts ==== | + | |
| - | To add a Concept for which there is an existing equivalent: | + | |
| - | + | ||
| - | * It should be recorded as a non-standard (source) Concept. | + | |
| - | * It should be mapped through a "Maps to" relationship to its standard equivalent. | + | |
| - | * All other relationships are optional and for QA and convenience. The standard Concept will take its place as the official representation. | + | |
| - | + | ||
| - | To add a Concept that does not have an equivalent: | + | |
| - | + | ||
| - | * It should be recorded as a standard Concept (standard_concept = ' | + | |
| - | * It should have hierarchical and lateral relationships in the same manner as RxNorm Concepts do. | + | |
| - | * It should form relationship to relevant drug classes. The relationship_id of these relationship do not have to follow the RxNorm standard, as it differs for every drug class. Classes are most often defined for Ingredients, | + | |
| - | + | ||
| - | Units used in the strength determination are not added. They must be mapped to a Standard UCUM Concept instead. If a unit is not present in the UCUM vocabulary it has to be added. | + | |
| - | + | ||
| - | === Implementation === | + | |
| - | Concepts from source vocabularies must be added following [[: | + | |
| - | + | ||
| - | === Result === | + | |
| - | + | ||
| - | Concepts belonging to source drug vocabularies have 'Maps to' relations to standard concepts in RxNorm and RxNorm Extension vocabularies. | + | |
| - | + | ||
| - | Equivalence relationship to valid non-standard concepts (like Brand Names and Dose forms) is indicated by entry in CONCEPT_RELATIONSHIP table with RELATIONSHIP_ID = ' | + | |
| - | + | ||
| - | Relationships between Drug Products or derivatives (Drug Forms and Components) are connected through CONCEPT_RELATIONSHIP_STAGE records with the the following relationship_id values: | + | |
| - | + | ||
| - | ^ Concept Class 1 ^ Concept Class 2 ^ Relationship ID ^ | + | |
| - | | Brand Name | Branded Drug | Brand name of | | + | |
| - | | Brand Name | Branded Drug Comp | Brand name of | | + | |
| - | | Brand Name | Branded Drug Form | Brand name of | | + | |
| - | | Brand Name | Ingredient | + | |
| - | | Brand Name | Quant Branded Drug | Brand name of | | + | |
| - | | Brand Name | Marketed Product | + | |
| - | | Branded Drug | Brand Name | RxNorm has ing | | + | |
| - | | Branded Drug | Branded Drug Comp | Consists of | | + | |
| - | | Branded Drug | Branded Drug Form | RxNorm is a | | + | |
| - | | Branded Drug | Branded Pack | Contained in | | + | |
| - | | Branded Drug | Clinical Drug | Tradename of | | + | |
| - | | Branded Drug | Clinical Drug Comp | Consists of | | + | |
| - | | Branded Drug | Dose Form | RxNorm has dose form | | + | |
| - | | Branded Drug | Quant Branded Drug | Has quantified form | | + | |
| - | | Branded Drug | Quant Clinical Drug | Tradename of | | + | |
| - | | Branded Drug | Marketed Product | + | |
| - | | Branded Drug Comp | Brand Name | RxNorm has ing | | + | |
| - | | Branded Drug Comp | Branded Drug | Constitutes | + | |
| - | | Branded Drug Comp | Clinical Drug Comp | Tradename of | | + | |
| - | | Branded Drug Comp | Quant Branded Drug | Constitutes | + | |
| - | | Branded Drug Form | Brand Name | RxNorm has ing | | + | |
| - | | Branded Drug Form | Branded Drug | RxNorm inverse is a | | + | |
| - | | Branded Drug Form | Clinical Drug Form | Tradename of | | + | |
| - | | Branded Drug Form | Dose Form | RxNorm has dose form | | + | |
| - | | Branded Drug Form | Quant Branded Drug | RxNorm inverse is a | | + | |
| - | | Branded Pack | Branded Drug | Contains | + | |
| - | | Branded Pack | Clinical Drug | Contains | + | |
| - | | Branded Pack | Clinical Pack | Tradename of | | + | |
| - | | Branded Pack | Dose Form | RxNorm has dose form | | + | |
| - | | Branded Pack | Quant Branded Drug | Contains | + | |
| - | | Branded Pack | Quant Clinical Drug | Contains | + | |
| - | | Branded Pack | Marketed Product | + | |
| - | | Clinical Drug | Branded Drug | Has tradename | + | |
| - | | Clinical Drug | Branded Pack | Contained in | | + | |
| - | | Clinical Drug | Clinical Drug Comp | Consists of | | + | |
| - | | Clinical Drug | Clinical Drug Form | RxNorm is a | | + | |
| - | | Clinical Drug | Clinical Pack | Contained in | | + | |
| - | | Clinical Drug | Dose Form | RxNorm has dose form | | + | |
| - | | Clinical Drug | Quant Branded Drug | Has tradename | + | |
| - | | Clinical Drug | Quant Clinical Drug | Has quantified form | | + | |
| - | | Clinical Drug | Marketed Product | + | |
| - | | Clinical Drug | Marketed Product | + | |
| - | | Clinical Drug Comp | Branded Drug | Constitutes | + | |
| - | | Clinical Drug Comp | Branded Drug Comp | Has tradename | + | |
| - | | Clinical Drug Comp | Clinical Drug | Constitutes | + | |
| - | | Clinical Drug Comp | Ingredient | + | |
| - | | Clinical Drug Comp | Ingredient | + | |
| - | | Clinical Drug Comp | Quant Branded Drug | Constitutes | + | |
| - | | Clinical Drug Comp | Quant Clinical Drug | Constitutes | + | |
| - | | Clinical Drug Form | Branded Drug Form | Has tradename | + | |
| - | | Clinical Drug Form | Clinical Drug | RxNorm inverse is a | | + | |
| - | | Clinical Drug Form | Dose Form | RxNorm has dose form | | + | |
| - | | Clinical Drug Form | Ingredient | + | |
| - | | Clinical Drug Form | Quant Clinical Drug | RxNorm inverse is a | | + | |
| - | | Clinical Pack | Branded Pack | Has tradename | + | |
| - | | Clinical Pack | Clinical Drug | Contains | + | |
| - | | Clinical Pack | Dose Form | RxNorm has dose form | | + | |
| - | | Clinical Pack | Quant Clinical Drug | Contains | + | |
| - | | Clinical Pack | Marketed Product | + | |
| - | | Dose Form | Branded Drug | RxNorm dose form of | | + | |
| - | | Dose Form | Branded Drug Form | RxNorm dose form of | | + | |
| - | | Dose Form | Branded Pack | RxNorm dose form of | | + | |
| - | | Dose Form | Clinical Drug | RxNorm dose form of | | + | |
| - | | Dose Form | Clinical Drug Form | RxNorm dose form of | | + | |
| - | | Dose Form | Clinical Pack | RxNorm dose form of | | + | |
| - | | Dose Form | Quant Branded Drug | RxNorm dose form of | | + | |
| - | | Dose Form | Quant Clinical Drug | RxNorm dose form of | | + | |
| - | | Dose Form | Marketed Product | + | |
| - | | Ingredient | + | |
| - | | Ingredient | + | |
| - | | Ingredient | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Marketed Product | + | |
| - | | Quant Branded Drug | Brand Name | RxNorm has ing | | + | |
| - | | Quant Branded Drug | Branded Drug | Quantified form of | | + | |
| - | | Quant Branded Drug | Branded Drug Comp | Consists of | | + | |
| - | | Quant Branded Drug | Branded Drug Form | RxNorm is a | | + | |
| - | | Quant Branded Drug | Branded Pack | Contained in | | + | |
| - | | Quant Branded Drug | Clinical Drug | Tradename of | | + | |
| - | | Quant Branded Drug | Clinical Drug Comp | Consists of | | + | |
| - | | Quant Branded Drug | Dose Form | RxNorm has dose form | | + | |
| - | | Quant Branded Drug | Quant Clinical Drug | Tradename of | | + | |
| - | | Quant Branded Drug | Marketed Product | + | |
| - | | Quant Clinical Drug | Branded Drug | Has tradename | + | |
| - | | Quant Clinical Drug | Branded Pack | Contained in | | + | |
| - | | Quant Clinical Drug | Clinical Drug | Quantified form of | | + | |
| - | | Quant Clinical Drug | Clinical Drug Comp | Consists of | | + | |
| - | | Quant Clinical Drug | Clinical Drug Form | RxNorm is a | | + | |
| - | | Quant Clinical Drug | Clinical Pack | Contained in | | + | |
| - | | Quant Clinical Drug | Dose Form | RxNorm has dose form | | + | |
| - | | Quant Clinical Drug | Quant Branded Drug | Has tradename | + | |
| - | | Quant Clinical Drug | Marketed Product | + | |
| - | | Quant Clinical Drug | Marketed Product | + | |
| - | | Supplier | + | |
| - | + | ||
| - | Name of the Branded and Clinical Pack concepts is built by combining names of the contents. | + | |
| - | + | ||
| - | Relationships between any Drug Concept Class and a Classfication Concept Class is recorded through the "Drug has drug class" and "Drug class of drug" generic relationship pair. | + | |
| - | + | ||
| - | ** Inferring of missing Concept Classes ** | + | |
| - | + | ||
| - | After RxNorm Extension Standard concept with the fullest attribute set is created for each source entity, all missing preceding Concept Classes are inferred from the existing ones, from bottom upwards. | + | |
| - | + | ||
| - | ^Concept Class^Defined by^ | + | |
| - | |Clinical Drug Component|Ingredient-strength. Note that Clinical Components are always single-Ingredient. This is in contrast to all other Concept Classes| | + | |
| - | |Branded Drug Component|Ingredient-strength(s), | + | |
| - | |Clinical Drug Form|Ingredient(s), | + | |
| - | |Branded Drug Form|Ingredient(s), | + | |
| - | |Clinical Drug|Ingredient-strength(s), | + | |
| - | |Branded Drug|Ingredient-strength(s), | + | |
| - | |Quantified Clinical Drug|Ingredient-strength(s), | + | |
| - | |Quantified Branded Drug|Ingredient-strength(s), | + | |
| - | |Clinical Drug Box|Ingredient-strength(s), | + | |
| - | |Branded Drug Box|Ingredient-strength(s), | + | |
| - | |Quantified Clinical Box|Ingredient-strength(s), | + | |
| - | |Quantified Branded Box|Ingredient-strength(s), | + | |
| - | + | ||
| - | Even though all drug classes are inferred, only those will be written to the CONCEPT table that have no mapping to an existing equivalent Standard Concept. | + | |
documentation/international_drugs.1563977347.txt.gz · Last modified: by ekorchmar
